The Economist: Life Expectancy: Who Wants to Live Forever?

By The Data Team

OVER the past 100 years, mankind has made great leaps in eliminating diseases and learning how to keep people alive. The life expectancy of a person born in America in 1900 was just 47 years. Eighty years later that figure had increased to 70 years for men and 77 years for women. But since then progress has slowed: a boy born in America in 2013 is expected to live just six years longer than his 1990 cohort. And not all of his twilight years will be golden.

IOL SciTech: Tweet, Tweet, You're Ill

By Brady Dennis

One of the biggest hurdles to halting foodborne illness outbreaks is spotting the source of the problem – and spotting it quickly. More often than not, by the time authorities recognize an outbreak of salmonella, listeria or any of the other pathogens that sicken an estimated 48 million Americans each year, it already has had time to spread.

Read the full article.

Fox News: Experimental Gel Partially Protects against Genital Herpes

By Rueters

An experimental vaginal gel containing a drug used to treat the AIDS virus could prevent half of cases of genital herpes, according to a study done in South Africa.

Among women who used tenofovir gel, the annual rate of infection with the genital herpes virus, known as herpes simplex virus type 2 or HSV-2, was 10.2 percent versus a rate of 21 percent for women who used a placebo gel.

Huffington Post: Tackling Non-Communicable Diseases to Avoid Premature Deaths

By Bjørn Lomborg

In rich countries, the biggest causes of death are strokes, heart attacks and cancer, accounting for more than two-thirds of all deaths. But for the poorer world, people often assume that infectious diseases like diarrhea, tuberculosis, AIDS, malaria, measles and tetanus are the biggest killers. That is no longer true. While they are still substantial threats, broader availability of medication and vaccines along with higher living standards has caused such communicable diseases to drop dramatically to below 9 million deaths each year.

NBC News: New Long-Acting Malaria Drug Looks Promising

By Maggie Fox

Researchers have developed a new, long-acting malaria drug that they believe may help fight one of the world's biggest killers.

The drug, still known by its experimental name "DSM265," can stop the malaria parasite at several stages in its life cycle, the researchers report in the journal Science Translational Medicine. Tests in people have begun.

Pages